AiViva at 2024 Bio Asia-Taiwan
2024-07-25 - 2024-07-28 | Bio Asia-Taiwan 2024, Taipei Nangang Exhibition Center, Hall 2 (TaiNEX2 7F), Taipei, Taiwan
The Conference will focus on five major areas: Innovation Forum, Investment Summit, Regional Collaboration Forum, Company Presentations, and Satellite Symposia.
BIO Asia–Taiwan 2024 will again feature the renowned BIO One-on-One Partnering™ platform, an easy-to-use online meeting scheduling system to search for and identify potential partners, collaborators, investors and in- and out-licensing opportunities. Face-to-face meetings will be held over private and secure video links 24 hours a day during the event period. With over 5,500+ meeting requests made via the system during BIO Asia–Taiwan 2023 and with an 68% increase in meetings scheduled over the year before, partnering is again expected to be a highly popular activity.
BIO Asia–Taiwan 2024 will showcase Taiwan’s growing digital advantage in the biomed sector and highlight advances in biotech, pharmaceutical, medical devices, precision medicine, AI applications, ICT, IoT technologies, and new healthcare/medical investment opportunities.
Agenda: BIO Asia–Taiwan 2024 亞洲生技大會

AiViva BioPharma at 2024 LSX World Congress USA
2024-09-11 - 2024-09-12 | Hynes Convention Centre, 900 Boylston Street, Boston, MA, 02115, United States
Reach out to Shane at this meeting, or through LinkedIn, to explore strategic partnerships in ophthalmology and/or dermatology.

Find out more: https://informaconnect.com/lsx-world-congress-usa/

MedInvest Biotech & Pharma Investor Conference
2024-09-18 - 2024-09-19 | O’Melveny, 1301 6th Avenue, New York, NY, 10019, United States
AiViva attending the upcoming meeting of the MedInvest Biotech & Pharma Investor Conference will be held in New York City, NY on September 18-19, 2024.
The conference will feature two days of company presentations, panel discussions, and keynote talks. Both in-person and virtual meetings will be taking place during the two days of the conference. The presenting companies are developing and/or commercializing technologies across a broad spectrum of indications, including oncology, immunology, neurology, cardiology, diabetes, infectious diseases, pulmonary diseases, autoimmune diseases, respiratory diseases, urology, endocrinology, dermatology, pain management, and many others.

AiViva Excited to Attend Eyecelerator @ AAO 2024
2024-10-17 | McCormick Place, Chicago, IL, United States
Eyecelerator @ AAO 2024
Held twice per year, Eyecelerator conferences provide a full day of KOL-driven programs highlighting industry advancements, investment trends, and innovative new products disrupting eye care. There are valuable opportunities to network and explore new market potentials. Dozens of company showcases presenting novel clinical treatments and emerging technologies that are shaping the future of ophthalmology and expanded opportunities for audience questions and participation.
Learn more at: https://www.eyecelerator.com/

AiViva’s Abstract for 2024
Title: Ocular and Systemic Pharmacokinetic Profiles Following Periocular Administration of AIV007 Gel Formulation
Authors: Yi Zhao and Diane DS Tang-Liu

Ophthalmology Innovation Source (OIS) XIV
2024-11-22 - 2024-11-23 | Omni Hotel San Diego, 675 L Street, San Diego, CA, 92101, United States
AiViva presenting with over 150 companies at OIS XIV Ophthalmology Innovation Summit.
This event unites many capital, clinical, and corporate leaders presenting clinical insights, anterior and posterior ophthalmology segments both. We look forward to learning, networking and collaborating at OIS Summit.

AiViva Presenting at Octane's Aesthetics Tech Forum
2025-01-09 07:30 - 2025-01-10 14:00 (America/Los_Angeles) | Pendry Newport Beach, 690 Newport Center Drive, Newport Beach, CA, 92660, United States
Diane Tang-Liu, President & CEO of AiViva BioPharma, Inc., will be presenting data on their dermatology asset at the upcoming Aesthetics Tech Forum on January 9, 2025.
Octane’s Aesthetics Tech Forum is the premier event for physicians, industry professionals, investors, and entrepreneurs in the aesthetics technology space.
Learn more at: https://octaneoc.org/aesthetics-tech-forum/

AiViva at 43rd J.P. Morgan Healthcare Conference
2025-01-13 - 2025-01-16 | The Westin St. Francis, 335 Powell Street, San Francisco on Union Square 335 Powell Street, San Francisco, 94102, United States
Diane Tang-Liu, CEO and Founder of AiViva BioPharma, will be attending the many presentations and discussions at the annual J.P. Morgan Healthcare Conference in San Francisco. If you’re interested in meeting Diane at this event, contact Shane Cerrato, VP of Business Development.
Contact info: shane@aiviva.com
LinkedIn contact info: LINK
Please note: This event is by invitation only. Agenda available to invitees only.

AiViva will be at BIO Partnering
2025-01-13 - 2025-01-16 | San Francisco Marriott Marquis & Virtual, 80 Mission Street, San Francisco, CA, 94103, United States
Expecting an exciting week at JPM Week. BIO 1:1 Partnering offers opportunities to meet senior biotech executives, business development leaders, analysts and investors from leading companies around the globe. Reach out to me at this event to explore strategic partnerships in dermatology. We are looking forward to meeting you!

Contact info: shane@aiviva.com or on LinkedIn
Learn more about the Biotechnology Innovation Organization (BIO): LINK

AiViva at Biocom California
2025-02-25 - 2025-02-27 | The Lodge at Torrey Pines, 11480 N. Torrey Pines Road, La Jolla, CA, 92037, United States
AiViva attending Global Life Science Partnering & Investor Conference presented by Biocom California. Location in beautiful LaJolla, California.
Dates of event: February 25-27, 2025

AiViva at #AAD2025
2025-03-07 - 2025-03-11 | Orange County Convention Center, 9800 International Drive, Orlando, FL, 32819, United States
Darlene Deecher, Vice President, Clinical Development, will be speaking at the American Academy of Dermatology (AAD) Annual Meeting on March 7-11, 2025 in Orlando, Florida.
AAD is the largest, most influential, and representative dermatology group in the United States. It is also the premier dermatology education event of the year led by dermatology experts and the best time to connect with peers and industry leaders. For more information: https://www.aad.org/member/meetings-education/am25
If you’d like to connect with Dr. Deecher, feel free to contact her for an appointment at AAO: darlene@aiviva.com

Join AiViva BioPharma at LSI USA Summit 2025
2025-03-17 - 2025-03-21 | CA
AiViva partnering with industry-leading executives building Medtech, from emerging companies, venture capital and private equity firms to family offices and small business.
March 17th – 21st in Dana Point, CA

AiViva Virtual Partnering with RESI EUROPE 2025
2025-04-01 - 2025-04-03 | CA
AiViva excited to attend workshops and meetings related to Biotech, MedTech, healthcare innovation, cutting-edge technologies and regulatory challenges shaping the industry on how it impacts patient care.
If you wish to contact Shane Cerrato, Vice President, Business Development, you may contact him at: shane@aiviva.com
Learn more at: https://resiconference.com/

AiViva BioPharma at ARVO
2025-05-04 - 2025-05-08 | CA
AiViva BioPharma is excited to present posters at The Association for Research in Vision & Ophthalmology (ARVO) conference in Salt Lake City, Utah on May 6, 2025.
Presentation Number – Posterboard Number: 3782 – B0003 Translation
Abstract/Presentation Title: Periocular Administration of AIV007 Demonstrates Depot Formation for Prolonged Drug Release in Rabbits and Humans
Presentation Type: Poster Session
Session Number: 363
Session Title: Diabetic Macular Edema. Clinical Research
Session Date/Times: May 6, 2025 from 3:30 PM to 5:15 PM

Presentation Number – Posterboard Number: 3783 – B0004 CLIN Translation
Abstract/Presentation Title: Periocular Administration of AIV007 in the Treatment of Diabetic Macular Edema: Preliminary Phase 1 Trial Results
Presentation Type: Poster Session
Session Number: 363
Session Title: Diabetic Macular Edema. Clinical research
Session Date/Times: May 6, 2025 from 3:30 PM to 5:15 PM

If you attend ARVO 2025, please stop by and say hello! We look forward to meeting you.

AiViva is heading to BIO International 2025
2025-06-16 - 2025-06-19 | CA
We’re excited to announce that AiViva BioPharma will participate in the BIO International Convention 2025, which will take place this June in Boston!
With three clinical-stage programs and our proprietary JEL® long-acting injectable platform, AiViva is redefining how therapies are delivered. It focuses drugs precisely where needed, minimizing systemic exposure, and extending duration for up to six months. Our pipeline targets multi-billion-dollar markets across oncology, ophthalmology, and dermatology, with accelerated 505(b)(2) regulatory paths and IP protection into the 2040s.
We’re actively scheduling partnering meetings with investors, pharma partners, and innovators looking to collaborate.
Let’s meet in Boston and shape the next wave of targeted, long-acting therapies.
Agustin de la Calle, Vice President of Business Development:

https://www.linkedin.com/in/agustin-de-la-calle-4b0136/
office@aiviva.com

AiViva Attending OIS 2025
2025-07-29 | CA
AiViva attending the 2025 OIS RETINA INNOVATION SUMMIT, located in Long Beach, California.
Date of event is July 29, 2025.

AiViva Presenting at OIS 2025 - San Diego, CA
2025-11-21 - 2025-11-22 | CA
Where collaboration is driven by a deep sense of commitment to learn and share game-changing therapies in ophthalmology, Ophthalmology Innovation Source (OIS) gives the opportunity to network where extraordinary things happen when the right people connect!
Join AiViva at OIS as our CEO, Dr. Diane Tang-Liu, as she presents “AIV007 in nAMD and DME Results” on Saturday, November 22, 2025.
Diane and our Head of Business Development, Agustin de la Calle, will be happy to meet you at this networking event. If you are interested in meeting these two dynamic executives, reach out to Agustin at agustindlc@aiviva.com.
For more information on OIS: Ophthalmology Innovation Source

To listen to Dr. Tang-Liu’s 2024 OIS speaking event, click here:

2024 OIS Presentation Recording by Dr. Diane Tang-Liu, CEO *

∗ Disclaimer: Investigational product; early-stage data; not for promotional use.

AiViva Presenting at ATF 2026 Powered by Octane
2026-01-08 - 2026-01-09 | CA
AiViva BioPharma is pleased to join Octane Aesthetics Tech Forum this January 8–9, 2026 in Newport Beach as a Presenting Company. Diane Tang-Liu, CEO and President, is AiViva’s representative as well as Agustin de la Calle, Vice President of Business Development.
We look forward to discussions around AIV001, a clinical-stage dermatology program currently under evaluation in Phase I/IIa clinical studies.
In Phase I/IIa clinical studies, AIV001 is being evaluated as an investigational dermatology program in indications related to fresh and established scar modulation and exploratory approaches to surgical-free management of low-risk basal cell carcinoma (BCC), with assessments including safety, tolerability, histologic findings, and cosmetic outcomes.
Contact Agustin for appointments to meet with this dynamic duo: agustindlc@aiviva.com
https://www.octane-oc.org/event/atf2026/agenda
www.aiviva.com

UPDATE:
To listen to Dr. Tang-Liu’s 2026 ATF speaking event, click on link below:

2026 ATF Presentation Recording by Dr. Diane Tang-Liu, CEO *

∗ Disclaimer: Investigational product; early-stage data; not for promotional use.
